{"id":51442,"date":"2023-09-20T09:21:39","date_gmt":"2023-09-20T09:21:39","guid":{"rendered":"https:\/\/medsname.com\/arkamin\/"},"modified":"2026-09-12T04:33:28","modified_gmt":"2026-09-12T04:33:28","slug":"arkamin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/arkamin\/","title":{"rendered":"Arkamin"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin: 0 0 8px 0; font-size: 16px; font-weight: bold;\">\u26a1 Quick Answer \u2014 What is Arkamin?<\/h3>\n<p style=\"margin: 0;\"><strong>Arkamin<\/strong> \u00e9 um <strong>Comprimido de Clonidina 100 mcg<\/strong> from Torrent Pharma \u2014 a <strong>agonista alfa-2 adren\u00e9rgico de a\u00e7\u00e3o central (imidazolina) que reduz a efer\u00eancia simp\u00e1tica<\/strong>, atuando sobre <strong>os recetores adren\u00e9rgicos alfa-2 pr\u00e9-sin\u00e1pticos (e recetores imidazolina-1) no bulbo ventrolateral rostral<\/strong>. A clonidina foi introduzida pela Boehringer Ingelheim em 1966 como <strong>Catapres<\/strong>. Originalmente sintetizada como descongestionante nasal, uma observa\u00e7\u00e3o acidental de hipotens\u00e3o profunda num volunt\u00e1rio de ensaio levou \u00e0 sua reutiliza\u00e7\u00e3o como anti-hipertensivo. O uso moderno abrange hipertens\u00e3o (quarta linha e urg\u00eancia hipertensiva), <strong>ADHD<\/strong> (aprovado pela FDA nos EUA como Kapvay ER), <strong>abstin\u00eancia de opi\u00f3ides e nicotina<\/strong>, sintomas vasomotores menop\u00e1usicos, s\u00edndrome de Tourette, adjuvantes de dor (intratecal) e pr\u00e9-medica\u00e7\u00e3o anest\u00e9sica. Meia-vida 12-16 horas (oral); 20-24 horas (adesivo transd\u00e9rmico); in\u00edcio 30-60 minutos (oral); pico plasm\u00e1tico 1-3 horas; efeito anti-hipertensivo 2-4 horas; dura\u00e7\u00e3o 8-12 horas. Indica\u00e7\u00f5es prim\u00e1rias: <strong>hipertens\u00e3o resistente ou de quarta linha, urg\u00eancia hipertensiva (oral\/sublingual), ADHD, abstin\u00eancia de opi\u00f3ides\/nicotina, afrontamentos menop\u00e1usicos, adjuvantes de dor e anest\u00e9sicos<\/strong>. Dosagem t\u00edpica: <strong>Hipertens\u00e3o cr\u00f3nica:<\/strong> 100 mcg (0,1 mg) duas ou tr\u00eas vezes por dia, titulando at\u00e9 um m\u00e1ximo habitual de 800 mcg\/dia. <strong>N\u00e3o \u00e9 um anti-hipertensivo de primeira linha<\/strong> \u2014 reserve for fourth\/fifth-line after ACEi\/ARB, CCB, thiazide, and spironolactone. <strong>Urg\u00eancia hipertensiva (oral):<\/strong> 100-200 mcg loading dose, then 100 mcg every hour up to 600 mcg; lowers BP by 10-20% within 1-2 hours. Not for hypertensive emergency (end-organ damage) \u2014 use IV agents. <strong>Nunca interrompa o Arkamin abruptamente<\/strong> \u2014 rebound hypertension is severe and potentially life-threatening. For most hypertensive patients, modern treatment starts with an ACE inhibitor\/ARB, a calcium-channel blocker, a thiazide, and spironolactone before reaching for an alpha-blocker or centrally-acting agent.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Fabricante certificado pela OMS-GMP \u00b7 Embalagem discreta \u00b7 Envio mundial \u00b7 Mais de 1.400 avalia\u00e7\u00f5es verificadas <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<h3>Porqu\u00ea encomendar da MedsBase<\/h3>\n<p>Os nossos medicamentos gen\u00e9ricos s\u00e3o obtidos de fabricantes certificados pela WHO-GMP e enviados para todo o mundo em embalagens discretas e simples \u2014 sem o nome do medicamento no exterior da encomenda. Os pagamentos com cart\u00e3o s\u00e3o processados por um processador regulamentado (os descritores de extrato incluem um processador de pagamentos com cart\u00e3o regulamentado \u2014 nunca \u201cMedsBase\u201d ou qualquer nome de medicamento). Tamb\u00e9m s\u00e3o aceites criptomoedas e transfer\u00eancias banc\u00e1rias SEPA. Todas as encomendas est\u00e3o cobertas pela nossa Pol\u00edtica de Garantia de Reenvio.<\/p>\n<h2 class=\"wp-block-heading\">O que \u00e9 o Arkamin?<\/h2>\n<p>O Arkamin \u00e9 um comprimido oral de 100 mcg de Clonidina da Torrent Pharma, fornecido em embalagens de 30-90 comprimidos. A Clonidina foi introduzida pela Boehringer Ingelheim em 1966 como <strong>Catapres<\/strong>. Originalmente sintetizada como descongestionante nasal, uma observa\u00e7\u00e3o acidental de hipotens\u00e3o profunda num volunt\u00e1rio de ensaio levou \u00e0 sua reutiliza\u00e7\u00e3o como anti-hipertensivo. O uso moderno abrange hipertens\u00e3o (quarta linha e urg\u00eancia hipertensiva), <strong>ADHD<\/strong> (aprovado pela FDA nos EUA como Kapvay ER), <strong>abstin\u00eancia de opi\u00f3ides e nicotina<\/strong>, sintomas vasomotores da menopausa, s\u00edndrome de Tourette, adjuvantes na dor (intratecal) e pr\u00e9-medica\u00e7\u00e3o anest\u00e9sica.<\/p>\n<h2 class=\"wp-block-heading\">Como funciona a Clonidina<\/h2>\n<p>A Clonidina atua sobre <strong>os recetores adren\u00e9rgicos alfa-2 pr\u00e9-sin\u00e1pticos (e recetores imidazolina-1) no bulbo ventrolateral rostral<\/strong>. Os efeitos subsequentes:<\/p>\n<ul>\n<li><strong>Redu\u00e7\u00e3o do fluxo simp\u00e1tico central<\/strong> \u2014 activation of pre-synaptic alpha-2 receptors in the rostral ventrolateral medulla suppresses descending sympathetic tone to the peripheral vasculature and heart<\/li>\n<li><strong>Redu\u00e7\u00e3o da noradrenalina plasm\u00e1tica<\/strong> \u2014 circulating catecholamines fall 30-50% within hours; heart rate drops 5-15 bpm; BP drops 10-30 mmHg<\/li>\n<li><strong>Atividade do recetor de imidazolina-1<\/strong> \u2014 an additional sympathetic-suppressing mechanism unique to imidazoline agonists (clonidine, moxonidine); may contribute to better metabolic tolerability than older centrally-acting drugs<\/li>\n<li><strong>A\u00e7\u00e3o analg\u00e9sica espinhal e supraespinhal<\/strong> \u2014 blocks pain signal relay in the dorsal horn; basis for intrathecal clonidine in chronic pain and for anaesthetic-adjunct use<\/li>\n<li><strong>Supress\u00e3o dos sintomas de abstin\u00eancia noradren\u00e9rgica<\/strong> \u2014 reduces sweating, tremor, tachycardia, and hypertension during opioid, nicotine, and alcohol withdrawal<\/li>\n<li><strong>Melhoria do t\u00f3nus cortical pr\u00e9-frontal<\/strong> \u2014 proposed mechanism for ADHD benefit (enhances top-down inhibitory control)<\/li>\n<li><strong>A\u00e7\u00e3o anti-termorregulat\u00f3ria central<\/strong> \u2014 basis for menopausal hot-flush benefit<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Usos Aprovados e Baseados em Evid\u00eancias<\/h2>\n<ul>\n<li><strong>Hipertens\u00e3o resistente ou de quarta linha, urg\u00eancia hipertensiva (oral\/sublingual), PHDA, abstin\u00eancia de opi\u00e1ceos\/nicotina, afrontamentos menop\u00e1usicos, dor e adjuvantes anest\u00e9sicos<\/strong><\/li>\n<li><strong>Hipertens\u00e3o resistente<\/strong> (quarta\/quinta linha)<\/li>\n<li><strong>Urg\u00eancia hipertensiva<\/strong> (oral 100-200 mcg loading, then 100 mcg hourly) \u2014 not for emergency with end-organ damage<\/li>\n<li><strong>ADHD<\/strong> (aprovado pela FDA como Kapvay de liberta\u00e7\u00e3o prolongada; formas IR padr\u00e3o usadas off-label globalmente)<\/li>\n<li><strong>Abstin\u00eancia de opi\u00e1ceos e nicotina<\/strong> \u2014 autonomic symptom relief<\/li>\n<li><strong>Sintomas vasomotores menop\u00e1usicos (afrontamentos)<\/strong> \u2014 non-hormonal option<\/li>\n<li><strong>S\u00edndrome de Tourette<\/strong> e perturba\u00e7\u00f5es de tiques<\/li>\n<li><strong>Dor cr\u00f3nica<\/strong> \u2014 intrathecal clonidine for neuropathic or cancer pain<\/li>\n<li><strong>Pr\u00e9-medica\u00e7\u00e3o anest\u00e9sica e tremores peri-operat\u00f3rios<\/strong><\/li>\n<\/ul>\n<p><strong>Evid\u00eancia do ensaio pivotal:<\/strong> <strong>Estudo Cooperativo VA sobre Hipertens\u00e3o (1967-1970)<\/strong> \u2014 clonidine established as effective monotherapy in the era before ACEi, ARB, and CCB classes. <strong>An\u00e1lises de subgrupos do ALLHAT<\/strong> \u2014 clonidine-based regimens generally reduced BP equivalently to first-line classes but with worse tolerability. <strong>Ensaios pedi\u00e1tricos de TDAH de Connor et al.<\/strong> \u2014 clonidine IR effective for hyperarousal and sleep disturbance in ADHD, though psychostimulants remain first-line. <strong>Gold et al. (1978)<\/strong> \u2014 landmark demonstration of clonidine for opiate withdrawal \u2014 abolished autonomic symptoms (sweating, piloerection, tachycardia) without cross-dependence.<\/p>\n<h2 class=\"wp-block-heading\">Dosagem de Arkamin<\/h2>\n<p><strong>Dose prim\u00e1ria:<\/strong> <strong>Hipertens\u00e3o cr\u00f3nica:<\/strong> 100 mcg (0,1 mg) duas ou tr\u00eas vezes por dia, titulando at\u00e9 um m\u00e1ximo habitual de 800 mcg\/dia. <strong>N\u00e3o \u00e9 um anti-hipertensivo de primeira linha<\/strong> \u2014 reserve for fourth\/fifth-line after ACEi\/ARB, CCB, thiazide, and spironolactone. <strong>Urg\u00eancia hipertensiva (oral):<\/strong> 100-200 mcg loading dose, then 100 mcg every hour up to 600 mcg; lowers BP by 10-20% within 1-2 hours. Not for hypertensive emergency (end-organ damage) \u2014 use IV agents.<\/p>\n<p><strong>Outras indica\u00e7\u00f5es:<\/strong> <strong>TDAH (crian\u00e7as e adolescentes):<\/strong> 50-100 mcg \u00e0 hora de deitar inicialmente, aumentando para 100-400 mcg\/dia em doses divididas. As formula\u00e7\u00f5es de liberta\u00e7\u00e3o prolongada (Kapvay) s\u00e3o preferidas nos EUA. <strong>Abstin\u00eancia de opi\u00f3ides (al\u00edvio de sintomas auton\u00f3micos):<\/strong> 100-300 mcg tr\u00eas ou quatro vezes por dia, reduzindo gradualmente \u00e0 medida que a abstin\u00eancia resolve. <strong>Afrontamentos menop\u00e1usicos:<\/strong> 50-75 mcg duas vezes por dia. <strong>S\u00edndrome de Tourette:<\/strong> 25-100 mcg duas ou tr\u00eas vezes por dia. <strong>Cessa\u00e7\u00e3o tab\u00e1gica:<\/strong> 100-300 mcg\/dia (oral ou transd\u00e9rmico). <strong>Pr\u00e9-medica\u00e7\u00e3o anest\u00e9sica:<\/strong> 200-400 mcg por via oral 60 minutos antes da cirurgia.<\/p>\n<p><strong>Administra\u00e7\u00e3o:<\/strong> tomar com ou sem alimentos; as doses noturnas s\u00e3o maiores do que as diurnas para deslocar a seda\u00e7\u00e3o para o sono. N\u00e3o falte \u00e0s doses (risco de reca\u00edda).<\/p>\n<p><strong>Calend\u00e1rio de monitoriza\u00e7\u00e3o:<\/strong><\/p>\n<ul>\n<li><strong>Linha de base:<\/strong> tens\u00e3o arterial em dec\u00fabito e em p\u00e9 (registar queda postural), frequ\u00eancia card\u00edaca, ECG (rastreio de bradicardia), lista de medicamentos (verificar agentes interativos).<\/li>\n<li><strong>Semana 1-2:<\/strong> repetir a tens\u00e3o arterial (em dec\u00fabito e em p\u00e9), frequ\u00eancia card\u00edaca, revis\u00e3o de sintomas. Ajustar a dose para cima ou para baixo com base na tens\u00e3o arterial e tolerabilidade.<\/li>\n<li><strong>Semana 4-6:<\/strong> avaliar a tens\u00e3o arterial alvo; carga de sintomas; perguntar especificamente sobre doses perdidas.<\/li>\n<li><strong>Cont\u00ednuo:<\/strong> revis\u00e3o anual da tens\u00e3o arterial e card\u00edaca; nunca ficar sem stock (risco de hipertens\u00e3o de rebote).<\/li>\n<li><strong>Parar ou reduzir a dose em caso de:<\/strong> bradicardia grave, s\u00edncope, bloqueio AV de segundo ou terceiro grau, depress\u00e3o maior, seda\u00e7\u00e3o problem\u00e1tica sem melhoria em 4-8 semanas.<\/li>\n<\/ul>\n<p><strong>Descontinua\u00e7\u00e3o:<\/strong> <strong>CRITICAL \u2014 never stop clonidine abruptly.<\/strong> Hipertens\u00e3o de rebote com aumento da atividade simp\u00e1tica pode ocorrer dentro de 18-36 horas em doses &gt;300 mcg\/dia. <strong>Reduzir gradualmente ao longo de 2-4 semanas<\/strong>; se for prescrito um beta-bloqueante em simult\u00e2neo, interrompa primeiro o beta-bloqueante e depois a clonidina. Procure cuidados m\u00e9dicos urgentes em caso de dor de cabe\u00e7a intensa, dor no peito ou TA &gt;180\/110 ap\u00f3s doses esquecidas ou interrompidas.<\/p>\n<h2 class=\"wp-block-heading\">Considera\u00e7\u00f5es Pr\u00e1ticas para o Arkamin<\/h2>\n<ul>\n<li><strong>Rebound hypertension on abrupt discontinuation \u2014 CRITICAL, potentially life-threatening.<\/strong> Doses esquecidas ou interrup\u00e7\u00e3o s\u00fabita podem causar um aumento da atividade simp\u00e1tica em 18-36 horas: aumento da TA de 30-50 mmHg, taquicardia, suores, tremores e relatos raros de AVC, enfarte do mioc\u00e1rdio e encefalopatia hipertensiva. <strong>Reduza sempre a clonidina gradualmente ao longo de 2-4 semanas<\/strong> em vez de interromper abruptamente. O risco \u00e9 maior com doses &gt;300 mcg\/dia e em combina\u00e7\u00e3o com beta-bloqueantes.<\/li>\n<li><strong>Adesivo transd\u00e9rmico<\/strong> (Catapres TTS, 100\/200\/300 mcg per day patches applied weekly) gives smoother plasma levels and mitigates rebound risk \u2014 useful for patients with adherence issues.<\/li>\n<li><strong>Seda\u00e7\u00e3o e boca seca<\/strong> s\u00e3o quase universais no in\u00edcio; geralmente diminuem parcialmente ao longo de 2-4 semanas. Tome \u00e0 hora de deitar para a dose principal, de modo a transformar a seda\u00e7\u00e3o em sono.<\/li>\n<li><strong>Precau\u00e7\u00e3o com a co-terapia com beta-bloqueadores<\/strong> \u2014 if discontinuing, stop the beta-blocker first, then taper clonidine several days later; reverse order can cause especially severe rebound because the beta-blocker blocks the compensatory reflexes.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efeitos Secund\u00e1rios<\/h2>\n<p><strong>Comuns (&gt;1%):<\/strong><\/p>\n<ul>\n<li><strong>Seda\u00e7\u00e3o, sonol\u00eancia<\/strong> (muito comum, especialmente nas primeiras 2-4 semanas)<\/li>\n<li><strong>Boca seca<\/strong> (muito comum)<\/li>\n<li><strong>Tonturas, hipotens\u00e3o ortost\u00e1tica<\/strong><\/li>\n<li><strong>Pris\u00e3o de ventre<\/strong><\/li>\n<li><strong>Disfun\u00e7\u00e3o er\u00e9til e redu\u00e7\u00e3o da libido<\/strong><\/li>\n<li><strong>Depress\u00e3o, altera\u00e7\u00f5es de humor<\/strong><\/li>\n<li><strong>Bradicardia, bloqueio card\u00edaco<\/strong> (especialmente com co-terapia com beta-bloqueador ou digoxina)<\/li>\n<li><strong>Aumento de peso, reten\u00e7\u00e3o de sal<\/strong> ao longo de meses<\/li>\n<li><strong>Rea\u00e7\u00f5es cut\u00e2neas com adesivo transd\u00e9rmico<\/strong> (dermatite de contacto 10-50%)<\/li>\n<li><strong>Perturba\u00e7\u00e3o do sono, sonhos v\u00edvidos, pesadelos<\/strong><\/li>\n<\/ul>\n<p><strong>Incomum mas clinicamente importante:<\/strong><\/p>\n<ul>\n<li><strong>Crise hipertensiva de rebote<\/strong> on abrupt discontinuation \u2014 stroke, MI, hypertensive encephalopathy reported.<\/li>\n<li><strong>Bradicardia grave e bloqueio auriculoventricular<\/strong>, especialmente com co-terapia de beta-bloqueador, digoxina ou bloqueador dos canais de c\u00e1lcio n\u00e3o di-hidropirid\u00ednico (verapamil, diltiazem).<\/li>\n<li><strong>Seda\u00e7\u00e3o profunda<\/strong> interfering with work or driving \u2014 dose-limiting in some patients.<\/li>\n<li><strong>Depress\u00e3o<\/strong> ou agravamento de depress\u00e3o pr\u00e9-existente.<\/li>\n<li><strong>Disfun\u00e7\u00e3o do n\u00f3 sinusal, s\u00edncope<\/strong>.<\/li>\n<li><strong>Dermatite al\u00e9rgica de contacto grave com adesivo transd\u00e9rmico<\/strong> \u2014 rotate sites; stop if severe.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contra-indica\u00e7\u00f5es<\/h2>\n<ul>\n<li>Hipersensibilidade conhecida \u00e0 clonidina<\/li>\n<li>Bradiarritmia grave, s\u00edndrome do seio doente, bloqueio AV de segundo ou terceiro grau sem pacemaker<\/li>\n<li>Depress\u00e3o grave (relativa)<\/li>\n<li>Concurrent use of other central alpha-2 agonists (methyldopa, tizanidine) \u2014 additive hypotension and sedation<\/li>\n<li>Gravidez: geralmente evitada (preferir metildopa ou labetalol); os dados s\u00e3o limitados, n\u00e3o \u00e9 claramente teratog\u00e9nica, mas a experi\u00eancia \u00e9 muito maior com alternativas<\/li>\n<li>Aleitamento materno: passa significativamente para o leite materno<\/li>\n<\/ul>\n<p><strong>Gravidez:<\/strong> generally avoided as first-choice \u2014 methyldopa and labetalol have larger safety databases. Clonidine is not clearly teratogenic and is sometimes used as add-on therapy in resistant gestational hypertension.<\/p>\n<p><strong>Aleitamento materno:<\/strong> significant transfer to breast milk \u2014 monitor the infant for sedation, bradycardia, and poor feeding; consider alternative agents.<\/p>\n<h2 class=\"wp-block-heading\">Intera\u00e7\u00f5es medicamentosas<\/h2>\n<ul>\n<li><strong>Beta-blockers \u2014 CRITICAL.<\/strong> A co-terapia agrava a hipertens\u00e3o de rebote na suspens\u00e3o da clonidina. Se ambos os f\u00e1rmacos forem interrompidos em simult\u00e2neo, suspenda primeiro o beta-bloqueante v\u00e1rios dias antes, depois reduza gradualmente a clonidina. Os beta-bloqueantes tamb\u00e9m aumentam o risco de bradicardia quando combinados com clonidina.<\/li>\n<li><strong>Digoxina, CCBs n\u00e3o-di-hidropirid\u00ednicos (verapamil, diltiazem)<\/strong> \u2014 additive bradycardia and AV block.<\/li>\n<li><strong>Antidepressivos tric\u00edclicos e alfa-antagonistas<\/strong> \u2014 partially antagonise clonidine\u2019s antihypertensive effect; may require higher clonidine doses.<\/li>\n<li><strong>Depressores do SNC (opi\u00f3ides, benzodiazepinas, \u00e1lcool, gabapentinoides)<\/strong> \u2014 seda\u00e7\u00e3o aditiva.<\/li>\n<li><strong>Outros anti-hipertensivos de a\u00e7\u00e3o central (metildopa, tizanidina, moxonidina)<\/strong> \u2014 additive sedation and hypotension; usually not combined.<\/li>\n<li><strong>Mirtazapina<\/strong> \u2014 alpha-2 antagonism reduces clonidine effect.<\/li>\n<li><strong>Diur\u00e9ticos<\/strong> \u2014 synergistic BP-lowering; standard combination in resistant HTN.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">O Lugar do Arkamin na Hierarquia Anti-hipertensora<\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 14px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">N\u00edvel<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Classe \/ Exemplos<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Fun\u00e7\u00e3o<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Primeira linha<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Inibidores da ECA (<a href=\"https:\/\/medsbase.com\/pt-pt\/ramcor\/\">ramipril<\/a>), BRA (<a href=\"https:\/\/medsbase.com\/pt-pt\/telmaheal\/\">telmisartan<\/a>), BCC (<a href=\"https:\/\/medsbase.com\/pt-pt\/amlode\/\">amlodipine<\/a>), tiazidas (<a href=\"https:\/\/medsbase.com\/pt-pt\/natrilix-sr\/\">indapamide<\/a>, HCTZ)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Iniciar aqui para HTA recentemente diagnosticada<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Segundo\/terceiro agente<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Combina\u00e7\u00f5es dos anteriores (iECA+BCC, BRA+tiazida)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Quando um agente \u00e9 insuficiente<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Quarto agente (HTN resistente)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/pt-pt\/aldactone\/\">Espironolactona<\/a> (evid\u00eancia PATHWAY-2); beta-bloqueante; doxazosina<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Se a TA n\u00e3o estiver controlada com combina\u00e7\u00e3o de tr\u00eas f\u00e1rmacos em dose plena<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Quinto agente<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Bloqueadores alfa<\/strong> (<a href=\"https:\/\/medsbase.com\/pt-pt\/prazopress\/\">prazosina<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/hytrin\/\">terazosina<\/a>, doxazosina); agentes de a\u00e7\u00e3o central<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Adicionar se a espironolactona for inadequada ou contraindicada; preferir alfa-bloqueantes quando coexistir HBP<\/td>\n<\/tr>\n<tr style=\"background: #fff3cd;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Quinto \/ sexto agente<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Agentes de a\u00e7\u00e3o central<\/strong> (<a href=\"https:\/\/medsbase.com\/pt-pt\/arkamin\/\">clonidina<\/a>, moxonidina)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Adicionar para controlar HTA resistente; monitorizar efeito rebote e seda\u00e7\u00e3o<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Primeira linha na gravidez<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong><a href=\"https:\/\/medsbase.com\/pt-pt\/alphadopa\/\">Metildopa<\/a><\/strong>, <a href=\"https:\/\/medsbase.com\/pt-pt\/labebet\/\">labetalol<\/a>, nifedipina<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">HTA gestacional e HTA pr\u00e9-existente durante a gravidez<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Armazenamento<\/h2>\n<p>Store Arkamin below 25\u00b0C in the original blister pack. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3 class=\"wp-block-heading\">Porque \u00e9 t\u00e3o perigoso falhar doses de Arkamin?<\/h3>\n<p>Clonidine suppresses central sympathetic outflow. When clonidine levels fall abruptly, the stored sympathetic drive &#8220;rebounds&#8221; within 18-36 hours \u2014 BP surges 30-50 mmHg, heart rate rises, and the patient sweats, tremors, and develops severe headache. Case reports describe rebound stroke, myocardial infarction, and hypertensive encephalopathy. This risk is greatest at doses above 300 mcg\/day and with concurrent beta-blockade. <strong>Nunca interrompa a clonidina abruptamente<\/strong> \u2014 taper over 2-4 weeks under medical supervision. Always order repeat supply 1-2 weeks before running out.<\/p>\n<h3 class=\"wp-block-heading\">O Arkamin provoca sonol\u00eancia?<\/h3>\n<p>Yes \u2014 sedation and daytime somnolence are the most common complaints, affecting up to half of patients in the first 2-4 weeks. It usually improves substantially by week 4-6. Strategies: shift more of the daily dose to bedtime so sedation occurs during sleep; avoid alcohol and other CNS depressants; do not drive or operate machinery until you know how Arkamin affects you. If sedation remains unacceptable after 6-8 weeks, switch to an alternative (moxonidine, methyldopa in pregnancy only, or a different antihypertensive class).<\/p>\n<h3 class=\"wp-block-heading\">Posso tomar Arkamin com \u00e1lcool?<\/h3>\n<p>Light, occasional drinking is usually tolerated. Regular or heavy drinking substantially potentiates the orthostatic hypotension and sedation of Arkamin \u2014 falls, blackouts, and accidents become more likely. Patients at higher risk (elderly, previous falls, concurrent diuretics or sedatives) should avoid alcohol altogether on this medication.<\/p>\n<h3 class=\"wp-block-heading\">O Arkamin pode ser usado para TDAH?<\/h3>\n<p>Yes \u2014 clonidine is FDA-approved in the United States as extended-release <strong>Kapvay<\/strong> for ADHD in children and adolescents, and is used off-label (as immediate-release) internationally. It is not first-line (psychostimulants \u2014 methylphenidate, amphetamines \u2014 give larger mean effect sizes on core ADHD symptoms), but clonidine has a specific niche in hyperarousal, sleep onset, tics, and stimulant-side-effect management. Typical paediatric dose: 50-100 mcg at bedtime initially, titrating to 100-400 mcg\/day in divided doses under specialist supervision.<\/p>\n<h3 class=\"wp-block-heading\">E se me esquecer de uma dose?<\/h3>\n<p><strong>Tome a dose esquecida assim que se lembrar<\/strong>, even if it is close to the next scheduled dose \u2014 clonidine\u2019s rebound-hypertension risk means that missed doses must be replaced promptly. If you realise within 6 hours, take the missed dose and continue as normal. If more than 12 hours have passed and rebound symptoms (severe headache, palpitations, sweating) are emerging, take the dose and seek urgent medical review. Never let your supply run out \u2014 order repeat prescriptions 1-2 weeks before the current stock is exhausted.<\/p>\n<h3 class=\"wp-block-heading\">Posso parar o Arkamin se a minha TA estiver controlada?<\/h3>\n<p><strong>N\u00e3o abruptamente.<\/strong> A hipertens\u00e3o de rebote dentro de 18-36 horas ap\u00f3s parar a clonidina pode precipitar AVC, enfarte do mioc\u00e1rdio ou encefalopatia hipertensiva. Sempre reduza gradualmente ao longo de 2-4 semanas sob supervis\u00e3o m\u00e9dica. Se estiver a tomar um beta-bloqueante, pare primeiro o beta-bloqueante e depois reduza gradualmente a clonidina alguns dias depois.<\/p>\n<h3 class=\"wp-block-heading\">Posso tomar Arkamin na gravidez?<\/h3>\n<p>Generally no. Pregnancy antihypertensives of choice are methyldopa, labetalol, and nifedipine \u2014 Arkamin is not first-line in pregnancy. Switch to one of those before conception or as soon as pregnancy is confirmed, under specialist supervision.<\/p>\n<h3 class=\"wp-block-heading\">Onde posso comprar Arkamin online?<\/h3>\n<p>Pode comprar Arkamin (100 mcg de clonidina, 30-90 comprimidos) na MedsBase com embalagem discreta e envio mundial.<\/p>\n<h2 class=\"wp-block-heading\">Anti-hipertensores Relacionados na MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/aldactone\/\">Aldactone \u2014 Spironolactone 25\/50\/100 mg (PATHWAY-2 4th-line)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/alphadopa\/\">Alphadopa \u2014 Methyldopa 250 mg (pregnancy-safe HTN)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/hytrin\/\">Hytrin \u2014 Terazosin 1\/2\/5 mg (AbbVie)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/minipress-xl\/\">Minipress XL \u2014 Prazosin ER 2.5\/5 mg (Pfizer)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/ramcor\/\">Ramcor \u2014 Ramipril 2.5\/5\/10 mg (ACEi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/telma-h\/\">Telma H \u2014 Telmisartan + HCTZ combination<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/high-blood-pressure-medication\/\"><strong>Ver todos os Medicamentos para Hipertens\u00e3o<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background: #fff3f3; border-left: 4px solid #d9534f; padding: 16px 20px; margin: 24px 0; border-radius: 4px;\"><strong>\u2695 Medical Disclaimer.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Hypertension, heart failure, and arrhythmias require diagnosis, monitoring, and dose individualisation by a doctor \u2014 always use beta-blockers under medical guidance.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternativas Relacionadas<\/h3>\n<p>Outros produtos em <strong>Condi\u00e7\u00f5es Cr\u00f3nicas<\/strong> que os clientes tamb\u00e9m visualizam:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/robinax\/\">Robinax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/affexor-xr\/\">Affexor XR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/xyzal\/\">Xyzal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/duolin-inhaler\/\">Inalador Duolin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/noltrexate\/\">Noltrexate<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>O Arkamin s\u00e3o comprimidos de clonidina 100 mcg da Torrent Pharma \u2014 o agonista alfa-2 adren\u00e9rgico de a\u00e7\u00e3o central original (Catapres da Boehringer Ingelheim, 1966). Reduz a efer\u00eancia simp\u00e1tica central; diminui a noradrenalina perif\u00e9rica em 30-50%. Utiliza\u00e7\u00f5es: hipertens\u00e3o de quarta\/quinta linha, urg\u00eancia hipertensiva, PHDA (aprovado pela FDA como Kapvay XR nos EUA), abstin\u00eancia de opi\u00f3ides e nicotina, afrontamentos menop\u00e1usicos, s\u00edndrome de Tourette, adjuvante anest\u00e9sico. CR\u00cdTICO \u2014 nunca interromper abruptamente (risco de hipertens\u00e3o de rebote com AVC, enfarte do mioc\u00e1rdio).<\/p>","protected":false},"featured_media":51443,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3357,3358],"class_list":{"0":"post-51442","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-arkamin","11":"product_tag-clonidine","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/51442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=51442"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/51443"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=51442"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=51442"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=51442"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=51442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}